Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Dr. Oz and iHeartMedia Announce Multiplatform Content Partnership

NEW YORK, April 30, 2015 /PRNewswire/ — Dr. Mehmet Oz announced today a  partnership with iHeartMedia that will deliver Dr. Oz’s incredibly popular consumer brand and content across iHeartMedia’s spectrum of media platforms — broadcast, digital and mobile.  “I have always seen radio as a terrific way to reach people in their daily routines and […]

Read More »

DNA Sequencing Market Will Exceed $20 Billion, Says Illumina CEO Jay Flatley

Illumina, one of the most important companies in biomedicine, is still barely known to the public. But scientists, diagnostics makers, physicians, and Wall Street look at the company with a mix of fear and awe. Just as Intel became the company that sparked so much of the computer revolution, Illumina has risen to prominence as […]

Read More »

Betting On China For New Drug Development

Healthcare investment firm OrbiMed manages over $14 billion in public and private equity, nearly $1.4 billion of which is focused on Asia. With 23 private equity investments in Asia, OrbiMed is spreading its interests across the healthcare spectrum, including drugs, medical devices, services and enabling technology. Jonathan Wang, senior managing director at OrbiMed, joined the […]

Read More »

Alex Rodriguez, Willie Mays And Adderall At Work

Here’s why you should pay close attention to the Alex Rodriguez story: How people respond to what he accomplishes will reveal much about emerging attitudes towards the (mis)use of ADHD stimulant medications, like Adderall, in the workplace. For those who don’t even glance at the sports pages, A-Rod, the Yankees’ DH, has come back strong […]

Read More »

How Lead Product Dependency Shapes Corporate Strategy In Pharma

A number of recent high-profile events in the pharmaceutical industry have showcased the significance of lead product dependency – that is, the proportion of revenues a company derives from its largest selling drug – on corporate strategy. Indeed, lead product dependency has played an integral role in two recently proposed acquisitions with a combined value […]

Read More »

Jennifer Lopez, Founder Of BodyLab, Invites Women Across The Country To Join Her In The Be The Girl Weight Loss Challenge

LOS ANGELES, April 27, 2015 /PRNewswire/ — The revolutionary lifestyle brand for women, BodyLab by Jennifer Lopez, has just announced their nationwide #BeTheGirl Challenge encouraging women to be the girl of their dreams. The four-week registration period begins on April 27th. In an effort to combat the rising rate of obesity in the United States, the […]

Read More »

GlaxoSmithKline Consumer Healthcare Announces Availability of Nicorette® mini Lozenge

PARSIPPANY, N.J., April 27, 2015 /PRNewswire/ — GlaxoSmithKline Consumer Healthcare (GSKCH) today announced 2 mg and 4 mg Nicorette®mini Lozenge is now available at most retail shelves in the US following a supply shortage. In February 2014, GSKCH voluntarily recalled all nicotine lozenges from warehouses and distributors manufactured at a site in Aiken, S.C. after manufacturing issues […]

Read More »

Astellas Launches CRESEMBA® (isavuconazonium sulfate) in the United States for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis

NORTHBROOK, Ill., April 27, 2015 /PRNewswire/ — Astellas announced today that CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, is now available in the United States for the treatment of adult patients with invasive aspergillosis and invasive mucormycosis (also known as zygomycosis). These are life-threatening fungal infections predominantly occurring in immunocompromised patients. On March 6, 2015, the […]

Read More »

Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers

CHAPEL HILL, N.C., April 24, 2015 /PRNewswire/ — New technologies and online platforms have dramatically increased the ability of consumers to educate themselves about products and companies. Likewise, these same technologies have expanded the tools and techniques available to market researchers seeking insights into consumer behavior. Given the changing consumer marketplace, it’s imperative that organizations adjust […]

Read More »

Drug overlaps, shortages may complicate Teva bid for Mylan

A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Reuters/Ronen Zvulun (Reuters) – Teva Pharmaceutical Industries’ bid for Mylan NV would create a company controlling nearly 25 percent of the U.S. generics market, including drugs in short supply, according to industry experts […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom